BRIEF-Elanco Animal Health Inc Intends To Carve Out Its Microbiome Research And Development Platform
BRIEF-Elanco Animal Health Inc Intends To Carve Out Its Microbiome Research And Development Platform
Oct 5 (Reuters) - Elanco Animal Health Inc ELAN.N :
路透10月5日電-Elanco Animal Health Inc ELAN.N：
* ELANCO ANIMAL HEALTH - INTENDS TO CARVE OUT ITS MICROBIOME RESEARCH AND DEVELOPMENT PLATFORM, AIMING TO CREATE A PRIVATELY FUNDED, INDEPENDENT, BIOPHARMACEUTICAL COMPANY
*Elanco動物健康-打算開拓其微生物組研發平台，旨在創建一傢俬人出資的獨立生物製藥公司
* ELANCO ANIMAL HEALTH INC - WILL EXPLORE STRUCTURES WITH BOTH STRATEGIC AND FINANCIAL SPONSORS, AND MAY RETAIN A MINORITY STAKE IN THIS NEW ENTITY
*Elanco動物健康公司-將探索與戰略和財務贊助商的結構，並可能保留這個新實體的少數股權
* ELANCO ANIMAL HEALTH INC - POTENTIAL CARVE-OUT IS EXPECTED TO BE COMPLETED BY END OF Q1 OF 2022
*Elanco Animal Health Inc-潛在的剝離預計將於2022年第一季度末完成
* ELANCO ANIMAL HEALTH INC - ELLEN DE BRABANDER JOINS ELANCO TO LEAD INNOVATION AND REGULATORY AFFAIR
*Elanco動物健康公司-Ellen DE Brabander加入Elanco領導創新和監管事務
* ELANCO ANIMAL HEALTH INC - ELANCO CONTINUES TO EXPECT $600 TO
*Elanco動物健康公司-Elanco繼續預計600美元至
$700 MILLION IN INNOVATION REVENUE BY 2025
到2025年創新收入將達到7億美元
* ELANCO ANIMAL HEALTH INC - AARON SCHACHT TRANSITIONS TO LEAD THE CARVE-OUT OF ELANCO’S MICROBIOME RESEARCH AND DEVELOPMENT PLATFORM
*Elanco Animal Health Inc-Aaron Schacht過渡到領導Elanco微生物組研發平台的分拆
Further company coverage: ELAN.N
進一步的公司報道：ELAN.N